节点文献

肝细胞生长因子治疗肝脏损害116例疗效观察

Observation of Curative Efficacy of Hepatocyte Growth Factor in 116 Children with Liver Damage

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨延玲王台

【Author】 YANG Yan-ling~1,WANG Tai~2 (1.Department of Pediatrics;2.Department of Infection,the Affiliated Hospital of Yan′an University,Yan′an 716000,China)

【机构】 延安大学附属医院儿科延安大学附属医院感染科 陕西延安716000陕西延安716000

【摘要】 目的观察肝细胞生长因子(HGF)治疗肝脏损害患儿的效果。方法将肝脏损害患儿204例随机分成两组,对照组在治疗原发病同时,选用能量合剂保肝;治疗组在此基础上选用HGF保肝、降酶治疗,观察治疗过程中肝脏回缩及降酶效果。结果疗程结束后HGF治疗组丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBIL)3项指标下降幅度明显大于对照组,治疗组总有效率达96.5%,而对照组总有效率为75.0%,治疗组明显优于对照组,有显著差异(χ2=5.27 P<0.05)。结论选用HGF治疗肝脏损害,可明显缩短病程,提高临床治愈率。

【Abstract】 Objective To observe curative efficacy of hepatocyte growth factor(HGF) in treatment of children with liver damage.Methods Two hundred and four children with liver damage were divided randomly into control group and teatment group.The control group was chosed energy compounds at the same time of primary disease was treated,on the basis of the control group,the treatment group was chosed HGF to protect liver and decline enzyme,to observe efficacy of liver shrink and decline enzyme in the course of treatment.Results After the treatment,alanine aminotransferase(ALT),aspartate aminotransferase(AST) and total bilirubin(TBIL) decreased significantly in the treatment group with HGF.The total clinical efficacy was 96.5%,while the total clinical efficacy of the control group was 75.0%.The curative efficacy of treatment group surpassed that in the control group,the difference was obvious(χ~2=5.27 P<0.05).Conclusion HGF may shorten obviously clinical course and enhance curative efficacy.

【关键词】 肝脏损害肝细胞生长因子儿童
【Key words】 liver damagehepatocyte growth factorchild
  • 【文献出处】 实用儿科临床杂志 ,Journal of Applied Clinical Pediatrics , 编辑部邮箱 ,2006年07期
  • 【分类号】R725.7
  • 【被引频次】5
  • 【下载频次】54
节点文献中: 

本文链接的文献网络图示:

本文的引文网络